<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bertrand RE</submitter><funding>NEI NIH HHS</funding><funding>National Eye Institute</funding><funding>International Retinal Research Foundation</funding><funding>Foundation Fighting Blindness</funding><funding>Fight for Sight UK</funding><funding>Knights Templar Eye Foundation</funding><funding>National Institute for Health Research (NIHR)</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><pagination>488-497</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7936949</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>23(3)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Previous studies suggest that ceramide is a proapoptotic lipid as high levels of ceramides can lead to apoptosis of neuronal cells, including photoreceptors. However, no pathogenic variant in ceramide synthases has been identified in human patients and knockout of various ceramide synthases in mice has not led to photoreceptor degeneration.&lt;h4>Methods&lt;/h4>Exome sequencing was used to identify candidate disease genes in patients with vision loss as confirmed by standard evaluation methods, including electroretinography (ERG) and optical coherence tomography. The vision loss phenotype in mice was evaluated by ERG and histological analyses.&lt;h4>Results&lt;/h4>Here we have identified four patients with cone-rod dystrophy or maculopathy from three families carrying pathogenic varian</pubmed_abstract><journal>Genetics in medicine : official journal of the American College of Medical Genetics</journal><pubmed_title>Ceramide synthase TLCD3B is a novel gene associated with human recessive retinal dystrophy.</pubmed_title><pmcid>PMC7936949</pmcid><funding_grant_id>R01 EY022356</funding_grant_id><funding_grant_id>1S10RR026550</funding_grant_id><funding_grant_id>R01EY022356</funding_grant_id><funding_grant_id>BR-GE-0613-0618-BCM</funding_grant_id><funding_grant_id>P30 EY002520</funding_grant_id><funding_grant_id>S10 OD023469</funding_grant_id><funding_grant_id>R01 EY018571</funding_grant_id><pubmed_authors>Sampaio SAM</pubmed_authors><pubmed_authors>Thangavel C</pubmed_authors><pubmed_authors>Robson AG</pubmed_authors><pubmed_authors>Webster AR</pubmed_authors><pubmed_authors>Porto FBO</pubmed_authors><pubmed_authors>Wang J</pubmed_authors><pubmed_authors>Qian X</pubmed_authors><pubmed_authors>Bertrand RE</pubmed_authors><pubmed_authors>Lucy Raymond F</pubmed_authors><pubmed_authors>Carss KJ</pubmed_authors><pubmed_authors>Xiong KH</pubmed_authors><pubmed_authors>Ba-Abbad R</pubmed_authors><pubmed_authors>Simoes RT</pubmed_authors><pubmed_authors>Arno G</pubmed_authors><pubmed_authors>Chen R</pubmed_authors><pubmed_authors>Liang Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ceramide synthase TLCD3B is a novel gene associated with human recessive retinal dystrophy.</name><description>&lt;h4>Purpose&lt;/h4>Previous studies suggest that ceramide is a proapoptotic lipid as high levels of ceramides can lead to apoptosis of neuronal cells, including photoreceptors. However, no pathogenic variant in ceramide synthases has been identified in human patients and knockout of various ceramide synthases in mice has not led to photoreceptor degeneration.&lt;h4>Methods&lt;/h4>Exome sequencing was used to identify candidate disease genes in patients with vision loss as confirmed by standard evaluation methods, including electroretinography (ERG) and optical coherence tomography. The vision loss phenotype in mice was evaluated by ERG and histological analyses.&lt;h4>Results&lt;/h4>Here we have identified four patients with cone-rod dystrophy or maculopathy from three families carrying pathogenic varian</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-02T16:46:34.771Z</modification><creation>2022-02-09T16:00:29.972Z</creation></dates><accession>S-EPMC7936949</accession><cross_references><pubmed>33077892</pubmed><doi>10.1038/s41436-020-01003-x</doi></cross_references></HashMap>